Yes. All patients are monitored serially with CEA and CA 19.9. If bilirubin is elevated due to obstruction rather than hepatic metastases, CA 19.9 elevation relates to obstruction rather than cancer status. In patients who do not have elevated CEA or CA 19.9 on presentation, we utilize ctDNA as a ma...